3-25598334-ATCT-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PM4_SupportingBS2
The NM_001330700.2(TOP2B):c.4851_4853delAGA(p.Glu1617del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000838 in 1,610,400 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000098 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000082 ( 1 hom. )
Consequence
TOP2B
NM_001330700.2 disruptive_inframe_deletion
NM_001330700.2 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.47
Genes affected
TOP2B (HGNC:11990): (DNA topoisomerase II beta) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001330700.2. Strenght limited to Supporting due to length of the change: 1aa.
BS2
High AC in GnomAd4 at 15 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOP2B | NM_001330700.2 | c.4851_4853delAGA | p.Glu1617del | disruptive_inframe_deletion | 36/36 | ENST00000264331.9 | NP_001317629.1 | |
TOP2B | NM_001068.3 | c.4836_4838delAGA | p.Glu1612del | disruptive_inframe_deletion | 36/36 | NP_001059.2 | ||
TOP2B | XM_011534057.4 | c.4740_4742delAGA | p.Glu1580del | disruptive_inframe_deletion | 35/35 | XP_011532359.1 | ||
TOP2B | XM_047448821.1 | c.4725_4727delAGA | p.Glu1575del | disruptive_inframe_deletion | 35/35 | XP_047304777.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOP2B | ENST00000264331.9 | c.4851_4853delAGA | p.Glu1617del | disruptive_inframe_deletion | 36/36 | 5 | NM_001330700.2 | ENSP00000264331.4 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152238Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
15
AN:
152238
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000895 AC: 22AN: 245914Hom.: 0 AF XY: 0.0000825 AC XY: 11AN XY: 133318
GnomAD3 exomes
AF:
AC:
22
AN:
245914
Hom.:
AF XY:
AC XY:
11
AN XY:
133318
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000823 AC: 120AN: 1458044Hom.: 1 AF XY: 0.0000800 AC XY: 58AN XY: 724982
GnomAD4 exome
AF:
AC:
120
AN:
1458044
Hom.:
AF XY:
AC XY:
58
AN XY:
724982
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74502
GnomAD4 genome
AF:
AC:
15
AN:
152356
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2023 | This variant, c.4836_4838del, results in the deletion of 1 amino acid(s) of the TOP2B protein (p.Glu1612del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs769246397, gnomAD 0.02%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with TOP2B-related conditions. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at